2015 | BioSenic

Theodorus II SA

Read more about Theodorus II SA

Preparatory documents for the Annual General Shareholder Meeting on 28 May 2015 have been made available

Read more about Preparatory documents for the Annual General Shareholder Meeting on 28 May 2015 have been made available

Transparency declaration

Read more about Transparency declaration

Bone Therapeutics appoints Bank Degroof as Liquidity Provider

Read more about Bone Therapeutics appoints Bank Degroof as Liquidity Provider

Transparency declaration SRIW SA & Sofipôle SA

Read more about Transparency declaration SRIW SA & Sofipôle SA

Bone Therapeutics announces half-year results for 2015

Read more about Bone Therapeutics announces half-year results for 2015

Bone Therapeutics Provides Business Update for the Third Quarter of 2015

Read more about Bone Therapeutics Provides Business Update for the Third Quarter of 2015

Bone Therapeutics Expands Product Portfolio with New Research into Innovative Combined Cell-Matrix Product

Read more about Bone Therapeutics Expands Product Portfolio with New Research into Innovative Combined Cell-Matrix Product

Bone Therapeutics Announces Intention to Launch an Initial Public Offering on Euronext Brussels and Euronext Paris

Read more about Bone Therapeutics Announces Intention to Launch an Initial Public Offering on Euronext Brussels and Euronext Paris

Bone Therapeutics Demonstrates Efficacy in First Patient Cohort in ALLOB® Phase I/IIA Delayed-Union Trial

Read more about Bone Therapeutics Demonstrates Efficacy in First Patient Cohort in ALLOB® Phase I/IIA Delayed-Union Trial

Subscribe to 2015